Adam D Lazar

Title: Adam D. Lazar: Innovator in T-Cell Expansion

Introduction

Adam D. Lazar is a prominent inventor based in Culver City, CA (US). He has made significant contributions to the field of immunology, particularly in the area of T-cell expansion. His innovative methods have the potential to enhance cancer treatment through improved T-cell therapies.

Latest Patents

Adam D. Lazar holds 1 patent for his work titled "Primary T-cell expansion." This patent outlines methods for in-vitro primary T cell growth that enrich T cells in a blood sample. The methods involve stimulating the T cells with anti-CD2, anti-CD3, and/or anti-CD28, followed by expansion using a cytokine. Additionally, the patent describes methods for treating tumors in patients using the expanded T cells.

Career Highlights

Adam is currently employed at Nantbio, Inc., where he continues to develop innovative solutions in the field of biotechnology. His work focuses on enhancing the efficacy of T-cell therapies, which are crucial for cancer treatment.

Collaborations

Adam has collaborated with notable colleagues, including Krsto Sbutega and Peter Sieling. Their combined expertise contributes to the advancement of research and development in T-cell therapies.

Conclusion

Adam D. Lazar is a key figure in the field of immunology, with a focus on T-cell expansion methods that hold promise for cancer treatment. His innovative work at Nantbio, Inc. and his collaborations with other experts highlight his commitment to advancing medical science.